Search

Author/Creator Barbet, Jacques

1. 90Y-labelled anti-CD22 epratuzumab tetraxetan in adults with refractory or relapsed CD22-positive B-cell acute lymphoblastic leukaemia: a phase 1 dose-escalation study. Issue 3 (March 2015)

Authors:
Chevallier, Patrice; Eugene, Thomas; Robillard, Nelly; Isnard, Françoise; Nicolini, Franck; Escoffre-Barbe, Martine; Huguet, Françoise; Hunault, Mathilde; Marcais, Antoine; Gaschet, Joelle; Cherel, Michel; Guillaume, Thierry; Delaunay, Jacques; Peterlin, Pierre; Eveillard, Marion; Thomas, Xavier;...
Journal:
Lancet
Issue:
Volume 2:Issue 3(2015)
Page Start:
e108
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Consolidation anti-CD22 fractionated radioimmunotherapy with 90Y-epratuzumab tetraxetan following R-CHOP in elderly patients with diffuse large B-cell lymphoma: a prospective, single group, phase 2 trial. Issue 1 (January 2017)

Authors:
Kraeber-Bodere, Françoise; Pallardy, Amandine; Maisonneuve, Hervé; Campion, Loïc; Moreau, Anne; Soubeyran, Isabelle; Le Gouill, Steven; Tournilhac, Olivier; Daguindau, Etienne; Jardel, Henry; Morineau, Nadine; Bouabdallah, Krimo; Gyan, Emmanuel; Moles, Marie-Pierre; Gressin, Remy; Berthou, Christ...
Journal:
Lancet
Issue:
Volume 4:Issue 1(2017)
Page Start:
e35
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗